Virtual Clinical and Precision Medicine Tumor Boards-Cloud-Based Platform-Mediated Implementation of Multidisciplinary Reviews Among Oncology Centers in the COVID-19 Era: Protocol for an Observational Study.

COVID-19 cancer cloud-based digital health health services implementation multidisciplinary collaboration multidisciplinary communication multidisciplinary oncology consultations oncology platform precision medicine tumor virtual health virtual tumor board

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
10 Sep 2021
Historique:
received: 02 12 2020
accepted: 17 05 2021
revised: 26 04 2021
pubmed: 14 8 2021
medline: 14 8 2021
entrez: 13 8 2021
Statut: epublish

Résumé

Multidisciplinary tumor boards play a pivotal role in the patient-centered clinical management and in the decision-making process to provide best evidence-based, diagnostic, and therapeutic care to patients with cancer. Among the barriers to achieve an efficient multidisciplinary tumor board, lack of time and geographical distance play a major role. Therefore, the elaboration of an efficient virtual multidisciplinary tumor board (VMTB) is a key point to successfully obtain an oncology team and implement a network among health professionals and institutions. This need is stronger than ever during the COVID-19 pandemic. This paper presents a research protocol for an observational study focused on exploring the structuring process and the implementation of a multi-institutional VMTB in Sicily, Italy. Other endpoints include analysis of cooperation between participants, adherence to guidelines, patients' outcomes, and patient satisfaction. This protocol encompasses a pragmatic, observational, multicenter, noninterventional, prospective trial. The study's programmed duration is 5 years, with a half-yearly analysis of the primary and secondary objectives' measurements. Oncology care health professionals from various oncology subspecialties at oncology departments in multiple hospitals (academic and general hospitals as well as tertiary centers and community hospitals) are involved in a nonhierarchic manner. VMTB employs an innovative, virtual, cloud-based platform to share anonymized medical data that are discussed via a videoconferencing system both satisfying security criteria and compliance with the Health Insurance Portability and Accountability Act. The protocol is part of a larger research project on communication and multidisciplinary collaboration in oncology units and departments spread in the Sicily region. The results of this study will particularly focus on the organization of VMTBs, involving oncology units present in different hospitals spread in the area, and creating a network to allow best patient care pathways and a hub-and-spoke relationship. The present results will also include data concerning organization skills and pitfalls, barriers, efficiency, number, and types with respect to clinical cases and customer satisfaction. VMTB represents a unique opportunity to optimize patient management through a patient-centered approach. An efficient virtualization and data-banking system is potentially time-saving, a source for outcome data, and a detector of possible holes in the hull of clinical pathways. The observations and results from this VMTB study may hopefully be useful to design nonclinical and organizational interventions that enhance multidisciplinary decision-making in oncology. DERR1-10.2196/26220.

Sections du résumé

BACKGROUND BACKGROUND
Multidisciplinary tumor boards play a pivotal role in the patient-centered clinical management and in the decision-making process to provide best evidence-based, diagnostic, and therapeutic care to patients with cancer. Among the barriers to achieve an efficient multidisciplinary tumor board, lack of time and geographical distance play a major role. Therefore, the elaboration of an efficient virtual multidisciplinary tumor board (VMTB) is a key point to successfully obtain an oncology team and implement a network among health professionals and institutions. This need is stronger than ever during the COVID-19 pandemic.
OBJECTIVE OBJECTIVE
This paper presents a research protocol for an observational study focused on exploring the structuring process and the implementation of a multi-institutional VMTB in Sicily, Italy. Other endpoints include analysis of cooperation between participants, adherence to guidelines, patients' outcomes, and patient satisfaction.
METHODS METHODS
This protocol encompasses a pragmatic, observational, multicenter, noninterventional, prospective trial. The study's programmed duration is 5 years, with a half-yearly analysis of the primary and secondary objectives' measurements. Oncology care health professionals from various oncology subspecialties at oncology departments in multiple hospitals (academic and general hospitals as well as tertiary centers and community hospitals) are involved in a nonhierarchic manner. VMTB employs an innovative, virtual, cloud-based platform to share anonymized medical data that are discussed via a videoconferencing system both satisfying security criteria and compliance with the Health Insurance Portability and Accountability Act.
RESULTS RESULTS
The protocol is part of a larger research project on communication and multidisciplinary collaboration in oncology units and departments spread in the Sicily region. The results of this study will particularly focus on the organization of VMTBs, involving oncology units present in different hospitals spread in the area, and creating a network to allow best patient care pathways and a hub-and-spoke relationship. The present results will also include data concerning organization skills and pitfalls, barriers, efficiency, number, and types with respect to clinical cases and customer satisfaction.
CONCLUSIONS CONCLUSIONS
VMTB represents a unique opportunity to optimize patient management through a patient-centered approach. An efficient virtualization and data-banking system is potentially time-saving, a source for outcome data, and a detector of possible holes in the hull of clinical pathways. The observations and results from this VMTB study may hopefully be useful to design nonclinical and organizational interventions that enhance multidisciplinary decision-making in oncology.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/26220.

Identifiants

pubmed: 34387553
pii: v10i9e26220
doi: 10.2196/26220
pmc: PMC8437400
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e26220

Informations de copyright

©Livio Blasi, Roberto Bordonaro, Vincenzo Serretta, Dario Piazza, Alberto Firenze, Vittorio Gebbia. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 10.09.2021.

Références

JAMIA Open. 2019 Oct 07;2(4):505-515
pubmed: 32025647
J Oncol Pract. 2013 May;9(3):e77-80
pubmed: 23942505
Ann Surg Oncol. 2016 Aug;23(8):2430-7
pubmed: 27002814
BMJ Open. 2019 Oct 10;9(10):e031179
pubmed: 31601594
Am Soc Clin Oncol Educ Book. 2017;37:450-459
pubmed: 28561658
Br J Cancer. 2013 Jun 25;108(12):2433-41
pubmed: 23756866
Nat Rev Clin Oncol. 2019 Apr;16(4):205-206
pubmed: 30552396
BMC Health Serv Res. 2020 Jan 31;20(1):73
pubmed: 32005232
Int J Qual Health Care. 2016 Jun;28(3):332-8
pubmed: 27084499
J Pathol Inform. 2018 Jul 19;9:26
pubmed: 30167341
Curr Oncol. 2019 Jun;26(3):e385-e397
pubmed: 31285683
J Multidiscip Healthc. 2018 Jan 19;11:49-61
pubmed: 29403284
J Multidiscip Healthc. 2020 Feb 14;13:179-186
pubmed: 32103978
J Oncol Pract. 2015 Jan;11(1):e66-74
pubmed: 25466708
J Healthc Manag. 2014 May-Jun;59(3):177-93
pubmed: 24988672
BMC Cancer. 2012 May 29;12:202
pubmed: 22642614
Rare Tumors. 2019 May 08;11:2036361319841696
pubmed: 31105919
Ann Surg Oncol. 2012 Dec;19(13):4019-27
pubmed: 22820934
BMC Health Serv Res. 2014 Sep 08;14:377
pubmed: 25196248
Transl Oncol. 2016 Apr;9(2):163-165
pubmed: 27084433
J Thorac Dis. 2019 Mar;11(Suppl 4):S562-S565
pubmed: 31032074
BMJ Open. 2019 Nov 7;9(11):e028609
pubmed: 31699717
Transl Lung Cancer Res. 2015 Aug;4(4):448-55
pubmed: 26380186
Cancer Treat Rev. 2016 Jan;42:56-72
pubmed: 26643552

Auteurs

Livio Blasi (L)

Azienda di Rilievo Nazionale ad Alta Specializzazione Civico, Palermo, Italy.

Roberto Bordonaro (R)

Azienda di Rilievo Nazionale ad Alta Specializzazione Garibaldi, Catania, Italy.

Vincenzo Serretta (V)

Gruppo Studio Tumori Urologici Foundation for Cancer Research, Palermo, Italy.

Dario Piazza (D)

Gruppo Studio Tumori Urologici Foundation for Cancer Research, Palermo, Italy.

Alberto Firenze (A)

University of Palermo, Palermo, Italy.

Vittorio Gebbia (V)

La Maddalena Cancer Center, Palermo, Italy.

Classifications MeSH